TCEA2 and breast carcinoma: The T allele was predicted to disrupt the interaction between bta-miR-1291 with its putative target genes, increasing the protein levels of TCEA2 (transcription elongation factor A) and BCAR1 (breast cancer anti-estrogen resistance 1) (Figure 7, Supplementary Table S5).